25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INAF (Indofarma) Stock Analysis
Buy, Hold or Sell?

Let's analyze Indofarma together

I guess you are interested in Indofarma Tbk. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Indofarma’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Indofarma’s Price Targets

I'm going to help you getting a better view of Indofarma Tbk. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Indofarma Tbk

I send you an email if I find something interesting about Indofarma Tbk.

1. Quick Overview

1.1. Quick analysis of Indofarma (30 sec.)










1.2. What can you expect buying and holding a share of Indofarma? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
Rp-254.56
Expected worth in 1 year
Rp-232.25
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
Rp22.31
Return On Investment
17.7%

For what price can you sell your share?

Current Price per Share
Rp126.00
Expected price per share
Rp126.00 - Rp126.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Indofarma (5 min.)




Live pricePrice per Share (EOD)
Rp126.00
Intrinsic Value Per Share
Rp-686.38 - Rp-0.15
Total Value Per Share
Rp-940.94 - Rp-254.72

2.2. Growth of Indofarma (5 min.)




Is Indofarma growing?

Current yearPrevious yearGrowGrow %
How rich?-$78.8m-$45m-$50.2m-52.7%

How much money is Indofarma making?

Current yearPrevious yearGrowGrow %
Making money-$7.6m-$17.8m$10.1m133.3%
Net Profit Margin-150.5%-230.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Indofarma (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Indofarma?

Welcome investor! Indofarma's management wants to use your money to grow the business. In return you get a share of Indofarma.

First you should know what it really means to hold a share of Indofarma. And how you can make/lose money.

Speculation

The Price per Share of Indofarma is Rp126.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Indofarma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Indofarma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp-254.56. Based on the TTM, the Book Value Change Per Share is Rp5.58 per quarter. Based on the YOY, the Book Value Change Per Share is Rp-71.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Indofarma.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.000.0%0.000.0%-0.010.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.010.0%0.000.0%-0.010.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.000.0%-0.010.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.01-0.01-0.05-0.05-0.13-0.21-
Price to Earnings Ratio-3.89--2.00--4.74--6.64--46.51--14.97-
Price-to-Total Gains Ratio1.10--3.83--18.75--21.08--218.33--219.60-
Price to Book Ratio-0.49--0.42--18.80-5.96-10.31-13.81-
Price-to-Total Gains Ratio1.10--3.83--18.75--21.08--218.33--219.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0126
Number of shares79365
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (79365 shares)44.26-162.84
Gains per Year (79365 shares)177.05-651.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101771670-651-661
203543440-1303-1312
305315210-1954-1963
407086980-2605-2614
508858750-3257-3265
60106210520-3908-3916
70123912290-4560-4567
80141614060-5211-5218
90159315830-5862-5869
100177117600-6514-6520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%10.028.02.025.0%31.034.019.036.9%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%5.015.00.025.0%11.029.00.027.5%32.051.01.038.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%3.00.081.03.6%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%5.015.00.025.0%11.029.00.027.5%33.050.01.039.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Indofarma Tbk compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--114.5715.577+1954%-71.198+162%-33.502+129%-20.518+118%-10.978+110%
Book Value Per Share---254.562-307.308+21%-145.325-43%-127.929-50%-17.416-93%76.205-434%
Current Ratio--0.1280.139-8%0.455-72%0.554-77%0.891-86%0.931-86%
Debt To Asset Ratio--2.3742.402-1%1.558+52%1.614+47%1.267+87%0.947+151%
Debt To Equity Ratio----0%-0%7.331-100%5.622-100%3.666-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---972527255187.000-1254957391609.000+29%91927855701.500-1158%213270184002.667-556%2687888608323.500-136%5377249912244.000-118%
Eps---8.102-24.655+204%-57.525+610%-34.088+321%-21.539+166%-11.205+38%
Ev To Sales Ratio---6.614-7.072+7%-0.461-93%-1.891-71%0.156-4350%3.763-276%
Free Cash Flow Per Share---6.045-1.500-75%-13.118+117%-16.541+174%-6.951+15%-4.273-29%
Free Cash Flow To Equity Per Share---6.045-1.500-75%-5.731-5%-12.229+102%-1.110-82%-0.203-97%
Gross Profit Margin--1.0001.0000%1.036-3%1.046-4%0.589+70%1.529-35%
Intrinsic Value_10Y_max---0.154----------
Intrinsic Value_10Y_min---686.381----------
Intrinsic Value_1Y_max---14.639----------
Intrinsic Value_1Y_min---67.036----------
Intrinsic Value_3Y_max---32.839----------
Intrinsic Value_3Y_min---204.119----------
Intrinsic Value_5Y_max---37.604----------
Intrinsic Value_5Y_min---343.116----------
Market Cap390508005888.0000%390508005888.000390508005888.0000%1557383118720.000-75%1645075117310.167-76%4029917184900.100-90%6466996172486.700-94%
Net Profit Margin---0.683-1.505+120%-2.301+237%-1.422+108%-0.860+26%-0.447-35%
Operating Margin----0%-0.2710%-0.2500%-0.1330%-0.0690%
Operating Ratio--2.7563.370-18%3.628-24%2.828-3%2.078+33%1.536+79%
Pb Ratio-0.4950%-0.495-0.417-16%-18.800+3698%5.960-108%10.310-105%13.815-104%
Pe Ratio-3.8880%-3.888-2.004-48%-4.740+22%-6.635+71%-46.507+1096%-14.973+285%
Price Per Share126.0000%126.000126.0000%502.500-75%530.750-76%1300.200-90%2086.525-94%
Price To Free Cash Flow Ratio-5.2110%-5.211-4.790-8%-25.111+382%-13.107+152%-9.610+84%31.188-117%
Price To Total Gains Ratio1.1000%1.100-3.835+449%-18.753+1805%-21.083+2017%-218.326+19952%-219.599+20068%
Quick Ratio--0.0310.044-28%0.298-89%0.329-91%0.562-94%0.589-95%
Return On Assets---0.044-0.115+162%-0.213+386%-0.132+201%-0.081+84%-0.041-5%
Return On Equity----0%-0%-0.4780%-0.2940%-0.1500%
Total Gains Per Share--114.5715.577+1954%-71.198+162%-33.502+129%-20.518+118%-10.978+110%
Usd Book Value---78895602.393-95243129.259+21%-45040062.579-43%-39647003.125-50%-5394635.539-93%23621822.580-434%
Usd Book Value Change Per Share--0.0110.001+1954%-0.007+162%-0.003+129%-0.002+118%-0.001+110%
Usd Book Value Per Share---0.025-0.031+21%-0.015-43%-0.013-50%-0.002-93%0.008-434%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---97252725.519-125495739.161+29%9192785.570-1158%21327018.400-556%268788860.832-136%537724991.224-118%
Usd Eps---0.001-0.002+204%-0.006+610%-0.003+321%-0.002+166%-0.001+38%
Usd Free Cash Flow---1873632.420-464988.448-75%-4065495.806+117%-5126711.210+174%-2154698.626+15%-1258195.483-33%
Usd Free Cash Flow Per Share---0.0010.000-75%-0.001+117%-0.002+174%-0.001+15%0.000-29%
Usd Free Cash Flow To Equity Per Share---0.0010.000-75%-0.001-5%-0.001+102%0.000-82%0.000-97%
Usd Market Cap39050800.5890%39050800.58939050800.5890%155738311.872-75%164507511.731-76%402991718.490-90%646699617.249-94%
Usd Price Per Share0.0130%0.0130.0130%0.050-75%0.053-76%0.130-90%0.209-94%
Usd Profit---2510924.362-7641356.982+204%-17828505.541+610%-12149161.004+384%-7626012.549+204%-3948070.897+57%
Usd Revenue--3676204.9205087606.094-28%9936027.870-63%13131846.616-72%31921280.965-88%35539369.136-90%
Usd Total Gains Per Share--0.0110.001+1954%-0.007+162%-0.003+129%-0.002+118%-0.001+110%
 EOD+0 -0MRQTTM+21 -8YOY+15 -193Y+19 -165Y+17 -1810Y+12 -23

3.3 Fundamental Score

Let's check the fundamental score of Indofarma Tbk based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.888
Price to Book Ratio (EOD)Between0-1-0.495
Net Profit Margin (MRQ)Greater than0-0.683
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.031
Current Ratio (MRQ)Greater than10.128
Debt to Asset Ratio (MRQ)Less than12.374
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.044
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Indofarma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.556
Ma 20Greater thanMa 50126.000
Ma 50Greater thanMa 100126.000
Ma 100Greater thanMa 200126.000
OpenGreater thanClose126.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutical, and medical equipment; and engages in herb infusion, health support, private polyclinic, general practitioner, dentist, and internet trading applications activities. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.

Fundamental data was last updated by Penke on 2025-06-30 04:15:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Indofarma earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -68.3%Β means thatΒ Rp-0.68 for each Rp1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Indofarma Tbk:

  • The MRQ is -68.3%. The company is making a huge loss. -2
  • The TTM is -150.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-68.3%TTM-150.5%+82.2%
TTM-150.5%YOY-230.1%+79.7%
TTM-150.5%5Y-86.0%-64.4%
5Y-86.0%10Y-44.7%-41.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Indofarma is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -4.4% Return on Assets means thatΒ Indofarma generatedΒ Rp-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Indofarma Tbk:

  • The MRQ is -4.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-11.5%+7.1%
TTM-11.5%YOY-21.3%+9.8%
TTM-11.5%5Y-8.1%-3.4%
5Y-8.1%10Y-4.1%-3.9%
4.3.1.3. Return on Equity

Shows how efficient Indofarma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Indofarma generated Rp0.00Β for eachΒ Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Indofarma Tbk:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-29.4%+29.4%
5Y-29.4%10Y-15.0%-14.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Indofarma Tbk.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Indofarma is operatingΒ .

  • Measures how much profit Indofarma makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated Rp0.00 Β for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Indofarma Tbk:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-27.1%+27.1%
TTM-5Y-13.3%+13.3%
5Y-13.3%10Y-6.9%-6.4%
4.3.2.2. Operating Ratio

Measures how efficient Indofarma is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.76 means that the operating costs are Rp2.76 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Indofarma Tbk:

  • The MRQ is 2.756. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.370. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.756TTM3.370-0.614
TTM3.370YOY3.628-0.259
TTM3.3705Y2.078+1.291
5Y2.07810Y1.536+0.542
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Indofarma Tbk.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Indofarma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.13Β means the company has Rp0.13 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Indofarma Tbk:

  • The MRQ is 0.128. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.139. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.128TTM0.139-0.011
TTM0.139YOY0.455-0.316
TTM0.1395Y0.891-0.752
5Y0.89110Y0.931-0.040
4.4.3.2. Quick Ratio

Measures if Indofarma is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.03Β means the company can pay off Rp0.03 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Indofarma Tbk:

  • The MRQ is 0.031. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.044. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.031TTM0.044-0.012
TTM0.044YOY0.298-0.254
TTM0.0445Y0.562-0.519
5Y0.56210Y0.589-0.027
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Indofarma Tbk.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of IndofarmaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Indofarma to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 2.37Β means that Indofarma assets areΒ financed with 237.4% credit (debt) and the remaining percentage (100% - 237.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Indofarma Tbk:

  • The MRQ is 2.374. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.402. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.374TTM2.402-0.028
TTM2.402YOY1.558+0.843
TTM2.4025Y1.267+1.135
5Y1.26710Y0.947+0.320
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Indofarma is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has Rp0.00 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Indofarma Tbk:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.622-5.622
5Y5.62210Y3.666+1.957
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every Rp1 in earnings Indofarma generates.

  • Above 15 is considered overpriced butΒ always compareΒ Indofarma to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -3.89 means the investor is paying Rp-3.89Β for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Indofarma Tbk:

  • The EOD is -3.888. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.888. Based on the earnings, the company is expensive. -2
  • The TTM is -2.004. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.888MRQ-3.8880.000
MRQ-3.888TTM-2.004-1.884
TTM-2.004YOY-4.740+2.736
TTM-2.0045Y-46.507+44.503
5Y-46.50710Y-14.973-31.534
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Indofarma Tbk:

  • The EOD is -5.211. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.211. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.790. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.211MRQ-5.2110.000
MRQ-5.211TTM-4.790-0.420
TTM-4.790YOY-25.111+20.321
TTM-4.7905Y-9.610+4.819
5Y-9.61010Y31.188-40.798
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Indofarma is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -0.49 means the investor is paying Rp-0.49Β for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Indofarma Tbk:

  • The EOD is -0.495. Based on the equity, the company is expensive. -2
  • The MRQ is -0.495. Based on the equity, the company is expensive. -2
  • The TTM is -0.417. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.495MRQ-0.4950.000
MRQ-0.495TTM-0.417-0.078
TTM-0.417YOY-18.800+18.383
TTM-0.4175Y10.310-10.727
5Y10.31010Y13.815-3.505
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in IDR. All numbers in thousands.

Summary
Total Assets574,079,237
Total Liabilities1,363,035,261
Total Stockholder Equity-788,956,024
 As reported
Total Liabilities 1,363,035,261
Total Stockholder Equity+ -788,956,024
Total Assets = 574,079,237

Assets

Total Assets574,079,237
Total Current Assets141,603,918
Long-term Assets432,475,320
Total Current Assets
Cash And Cash Equivalents 7,575,323
Net Receivables 34,609,328
Inventory 56,423,790
Other Current Assets 390,451
Total Current Assets  (as reported)141,603,918
Total Current Assets  (calculated)98,998,891
+/- 42,605,026
Long-term Assets
Property Plant Equipment 334,241,787
Intangible Assets 2,150,232
Long-term Assets  (as reported)432,475,320
Long-term Assets  (calculated)336,392,019
+/- 96,083,301

Liabilities & Shareholders' Equity

Total Current Liabilities1,106,732,372
Long-term Liabilities256,302,889
Total Stockholder Equity-788,956,024
Total Current Liabilities
Short Long Term Debt 441,491,139
Accounts payable 275,972,470
Total Current Liabilities  (as reported)1,106,732,372
Total Current Liabilities  (calculated)717,463,609
+/- 389,268,763
Long-term Liabilities
Long term Debt 215,408,760
Capital Lease Obligations Min Short Term Debt835,312
Long-term Liabilities  (as reported)256,302,889
Long-term Liabilities  (calculated)216,244,071
+/- 40,058,818
Total Stockholder Equity
Retained Earnings -1,378,184,410
Total Stockholder Equity (as reported)-788,956,024
Total Stockholder Equity (calculated)-1,378,184,410
+/- 589,228,386
Other
Capital Stock309,926,750
Common Stock Shares Outstanding 3,099,268
Net Debt 649,324,576
Net Invested Capital -132,056,125
Net Working Capital -965,128,454
Property Plant and Equipment Gross 676,353,017



6.2. Balance Sheets Structured

Currency in IDR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-30
> Total Assets 
726,115,566
811,624,762
891,413,411
810,027,644
711,131,000
635,959,594
543,730,157
538,275,472
647,488,826
523,923,105
493,129,000
492,116,860
521,964,437
518,823,730
550,256,129
521,278,950
522,983,504
591,783,083
637,326,950
751,887,958
1,009,437,678
615,097,227
722,309,176
850,723,495
965,811,676
0
695,986,093
733,391,769
728,034,878
650,876,360
674,798,677
785,929,349
733,957,862
673,263,099
764,154,176
912,831,658
1,114,901,670
1,034,705,218
1,147,757,386
1,158,773,523
1,188,618,790
1,088,995,674
1,142,498,619
1,274,302,646
1,294,510,669
1,125,467,766
1,161,769,305
1,315,426,819
1,248,343,275
1,162,248,888
1,247,397,222
1,353,169,866
1,533,708,564
1,324,042,051
1,348,302,483
1,483,186,409
1,381,633,321
1,454,304,794
1,460,387,712
1,473,087,698
1,529,874,782
1,430,851,427
1,464,997,028
1,523,502,548
1,442,350,609
1,401,978,468
1,399,847,472
1,325,852,511
1,383,935,194
1,401,814,703
1,555,305,636
1,491,345,725
1,713,334,659
1,821,566,480
1,951,216,677
2,338,273,001
2,011,879,396
1,926,559,035
1,866,397,011
1,812,152,544
1,534,000,447
1,576,237,916
1,559,064,750
1,491,062,010
759,828,978
792,234,098
821,463,739
758,434,103
618,159,340
574,079,237
574,079,237618,159,340758,434,103821,463,739792,234,098759,828,9781,491,062,0101,559,064,7501,576,237,9161,534,000,4471,812,152,5441,866,397,0111,926,559,0352,011,879,3962,338,273,0011,951,216,6771,821,566,4801,713,334,6591,491,345,7251,555,305,6361,401,814,7031,383,935,1941,325,852,5111,399,847,4721,401,978,4681,442,350,6091,523,502,5481,464,997,0281,430,851,4271,529,874,7821,473,087,6981,460,387,7121,454,304,7941,381,633,3211,483,186,4091,348,302,4831,324,042,0511,533,708,5641,353,169,8661,247,397,2221,162,248,8881,248,343,2751,315,426,8191,161,769,3051,125,467,7661,294,510,6691,274,302,6461,142,498,6191,088,995,6741,188,618,7901,158,773,5231,147,757,3861,034,705,2181,114,901,670912,831,658764,154,176673,263,099733,957,862785,929,349674,798,677650,876,360728,034,878733,391,769695,986,0930965,811,676850,723,495722,309,176615,097,2271,009,437,678751,887,958637,326,950591,783,083522,983,504521,278,950550,256,129518,823,730521,964,437492,116,860493,129,000523,923,105647,488,826538,275,472543,730,157635,959,594711,131,000810,027,644891,413,411811,624,762726,115,566
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
706,558,231
620,006,143
0
752,593,795
777,629,146
663,918,677
710,296,838
822,356,479
848,840,281
674,988,758
695,711,481
850,856,377
782,887,635
692,465,908
776,486,056
884,034,551
1,068,157,389
841,111,212
850,655,900
974,667,813
853,506,464
876,774,534
0
0
930,982,222
0
0
906,309,835
867,493,107
821,772,098
822,886,070
744,220,914
829,103,602
842,408,041
1,010,386,301
942,532,840
1,134,732,820
1,218,982,174
1,343,061,113
1,694,219,292
1,411,390,100
1,330,604,656
1,269,800,491
1,217,338,562
863,577,052
907,676,617
889,573,539
816,980,401
198,991,900
236,400,692
268,351,684
208,949,618
134,191,242
141,603,918
141,603,918134,191,242208,949,618268,351,684236,400,692198,991,900816,980,401889,573,539907,676,617863,577,0521,217,338,5621,269,800,4911,330,604,6561,411,390,1001,694,219,2921,343,061,1131,218,982,1741,134,732,820942,532,8401,010,386,301842,408,041829,103,602744,220,914822,886,070821,772,098867,493,107906,309,83500930,982,22200876,774,534853,506,464974,667,813850,655,900841,111,2121,068,157,389884,034,551776,486,056692,465,908782,887,635850,856,377695,711,481674,988,758848,840,281822,356,479710,296,838663,918,677777,629,146752,593,7950620,006,143706,558,231000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133,417,373
20,889,864
0
22,521,704
194,902,806
64,541,815
29,193,377
40,873,166
121,432,026
22,529,501
32,788,698
11,555,929
135,754,602
17,889,195
12,779,008
14,790,339
313,472,667
28,012,820
28,491,012
19,256,779
56,233,906
14,222,420
0
0
182,587,625
0
0
30,220,436
129,324,891
16,599,163
13,849,325
16,026,619
151,387,944
60,034,889
51,459,436
27,099,940
158,178,407
19,908,271
117,961,154
350,547,508
380,814,191
295,886,104
260,694,840
269,345,253
269,751,395
249,332,573
258,164,172
209,807,114
17,070,940
12,373,284
10,613,055
7,721,189
10,114,018
7,575,323
7,575,32310,114,0187,721,18910,613,05512,373,28417,070,940209,807,114258,164,172249,332,573269,751,395269,345,253260,694,840295,886,104380,814,191350,547,508117,961,15419,908,271158,178,40727,099,94051,459,43660,034,889151,387,94416,026,61913,849,32516,599,163129,324,89130,220,43600182,587,6250014,222,42056,233,90619,256,77928,491,01228,012,820313,472,66714,790,33912,779,00817,889,195135,754,60211,555,92932,788,69822,529,501121,432,02640,873,16629,193,37764,541,815194,902,80622,521,704020,889,864133,417,373000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,000
-155,586
0
-155,586
0
0
0
0
0
0
0
0
0
0
0
0
-14,291,948
-14,241,818
-14,191,688
-14,141,558
-14,111,480
-14,066,363
0
0
-13,931,012
0
0
-13,800,106
-13,756,470
-20,677,724
-20,536,307
-20,386,873
-13,571,848
-19,979,109
-13,481,712
-13,441,233
-13,397,695
-13,354,156
-13,310,618
-13,267,080
35,000,000
35,000,000
35,000,000
35,000,000
39,000,000
39,000,000
39,000,000
35,000,000
0
0
0
0
0
0
00000035,000,00039,000,00039,000,00039,000,00035,000,00035,000,00035,000,00035,000,000-13,267,080-13,310,618-13,354,156-13,397,695-13,441,233-13,481,712-19,979,109-13,571,848-20,386,873-20,536,307-20,677,724-13,756,470-13,800,10600-13,931,01200-14,066,363-14,111,480-14,141,558-14,191,688-14,241,818-14,291,948000000000000-155,5860-155,58628,000000000000000000000000000000000000000
       Net Receivables 
104,539,681
222,901,065
223,674,140
212,405,202
97,677,000
130,826,571
102,329,077
127,227,825
234,968,784
105,081,278
79,664,086
82,700,875
149,420,334
147,942,663
177,712,678
75,552,386
117,885,988
147,207,965
127,166,818
278,396,861
250,188,766
141,474,911
143,309,675
299,680,226
213,638,783
0
204,998,423
168,118,591
307,805,123
242,661,325
227,338,155
315,999,652
278,659,663
117,696,812
333,419,349
458,723,206
340,160,251
354,350,085
426,958,926
521,913,396
421,384,527
402,838,103
383,219,934
478,624,615
490,990,857
391,552,403
371,233,489
578,714,358
410,329,897
428,663,722
449,757,383
536,352,916
431,627,401
488,190,522
441,981,185
600,873,554
476,819,772
509,912,247
477,794,694
457,292,205
463,307,279
475,182,736
411,478,798
455,982,547
299,691,683
183,453,386
213,825,810
229,173,622
294,542,572
302,601,802
748,292,008
393,506,055
826,130,685
950,221,525
939,120,071
513,926,000
379,499,000
357,336,000
325,211,000
280,610,000
301,274,274
343,610,664
326,226,493
319,789,990
62,429,133
60,247,688
104,103,229
55,924,884
43,650,622
34,609,328
34,609,32843,650,62255,924,884104,103,22960,247,68862,429,133319,789,990326,226,493343,610,664301,274,274280,610,000325,211,000357,336,000379,499,000513,926,000939,120,071950,221,525826,130,685393,506,055748,292,008302,601,802294,542,572229,173,622213,825,810183,453,386299,691,683455,982,547411,478,798475,182,736463,307,279457,292,205477,794,694509,912,247476,819,772600,873,554441,981,185488,190,522431,627,401536,352,916449,757,383428,663,722410,329,897578,714,358371,233,489391,552,403490,990,857478,624,615383,219,934402,838,103421,384,527521,913,396426,958,926354,350,085340,160,251458,723,206333,419,349117,696,812278,659,663315,999,652227,338,155242,661,325307,805,123168,118,591204,998,4230213,638,783299,680,226143,309,675141,474,911250,188,766278,396,861127,166,818147,207,965117,885,98875,552,386177,712,678147,942,663149,420,33482,700,87579,664,086105,081,278234,968,784127,227,825102,329,077130,826,57197,677,000212,405,202223,674,140222,901,065104,539,681
       Other Current Assets 
208,638,035
59,883,858
117,850,444
85,479,646
116,531,000
111,290,713
90,320,130
73,366,961
88,889,938
80,337,998
112,542,635
86,406,425
74,674,172
69,290,657
97,706,922
110,875,386
98,922,707
116,964,810
129,090,755
91,199,159
78,976,548
124,624,826
155,819,714
131,568,458
149,119,043
0
64,082,299
156,905,622
19,837,030
59,444,974
60,386,467
54,502,606
23,075,298
181,058,974
25,558,889
44,216,471
379,670,501
384,220,026
33,216,404
0
0
0
430,535,970
504,871,070
0
0
388,507,435
0
430,726,146
0
474,374,520
575,929,924
454,412,975
0
478,164,966
0
504,861,443
534,388,759
28,176,906
38,816,627
493,715,613
27,892,838
70,568,918
526,130,401
522,673,604
552,595,944
569,895,205
539,239,808
529,607,121
616,084,165
0
703,095,332
5,656,330
1,388,245
5,656,330
3,791,018
12,913,313
12,915,313
13,209,466
15,156,434
9,582,824
9,110,159
9,154,627
9,291,280
7,000,345
6,935,277
7,190,880
7,156,943
2,352,562
390,451
390,4512,352,5627,156,9437,190,8806,935,2777,000,3459,291,2809,154,6279,110,1599,582,82415,156,43413,209,46612,915,31312,913,3133,791,0185,656,3301,388,2455,656,330703,095,3320616,084,165529,607,121539,239,808569,895,205552,595,944522,673,604526,130,40170,568,91827,892,838493,715,61338,816,62728,176,906534,388,759504,861,4430478,164,9660454,412,975575,929,924474,374,5200430,726,1460388,507,43500504,871,070430,535,97000033,216,404384,220,026379,670,50144,216,47125,558,889181,058,97423,075,29854,502,60660,386,46759,444,97419,837,030156,905,62264,082,2990149,119,043131,568,458155,819,714124,624,82678,976,54891,199,159129,090,755116,964,81098,922,707110,875,38697,706,92269,290,65774,674,17286,406,425112,542,63580,337,99888,889,93873,366,96190,320,130111,290,713116,531,00085,479,646117,850,44459,883,858208,638,035
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
408,343,438
414,699,075
0
406,179,728
410,989,645
425,076,997
432,201,781
451,946,167
445,670,388
450,479,008
466,057,823
464,570,442
465,455,640
469,782,980
470,911,166
469,135,315
465,551,175
482,930,840
497,646,583
508,518,595
528,126,857
577,530,259
0
0
598,892,560
0
0
617,192,713
574,857,501
580,206,370
576,961,402
581,631,597
554,831,592
559,406,662
544,919,335
548,812,885
578,601,839
602,584,306
608,155,564
644,053,709
600,489,296
595,954,379
596,596,520
594,813,982
670,423,394
668,561,299
669,491,211
674,081,609
560,837,077
555,833,406
553,112,055
549,484,486
483,968,098
432,475,320
432,475,320483,968,098549,484,486553,112,055555,833,406560,837,077674,081,609669,491,211668,561,299670,423,394594,813,982596,596,520595,954,379600,489,296644,053,709608,155,564602,584,306578,601,839548,812,885544,919,335559,406,662554,831,592581,631,597576,961,402580,206,370574,857,501617,192,71300598,892,56000577,530,259528,126,857508,518,595497,646,583482,930,840465,551,175469,135,315470,911,166469,782,980465,455,640464,570,442466,057,823450,479,008445,670,388451,946,167432,201,781425,076,997410,989,645406,179,7280414,699,075408,343,438000000000000000000000000000000000000
       Property Plant Equipment 
93,952,102
100,585,134
112,021,153
121,980,732
120,464,000
114,509,791
111,631,966
108,419,707
104,937,407
100,403,540
97,810,621
98,843,891
99,673,412
98,434,804
94,660,424
92,046,712
87,788,345
86,775,344
84,795,295
81,278,471
82,009,711
79,249,724
74,073,807
76,440,507
89,228,326
0
96,992,348
103,573,125
100,990,757
99,867,401
102,567,073
100,807,070
96,937,464
95,724,781
92,972,739
91,421,861
342,984,242
340,058,137
336,705,192
332,345,075
339,196,270
349,522,011
355,502,715
364,474,075
367,912,767
367,919,722
374,919,313
378,259,002
394,584,546
393,855,836
394,225,347
395,100,671
398,427,200
401,759,957
402,396,930
415,879,308
425,706,697
458,366,330
476,430,139
498,607,638
487,333,744
489,162,038
484,822,886
492,278,631
496,765,557
480,428,075
478,468,286
481,993,003
469,100,892
468,300,523
463,568,070
460,293,064
471,236,168
473,178,423
478,936,651
476,241,732
477,146,968
480,037,634
475,092,335
469,581,068
462,994,107
460,790,335
454,787,851
451,125,521
411,350,603
404,581,736
400,259,447
396,400,265
383,389,933
334,241,787
334,241,787383,389,933396,400,265400,259,447404,581,736411,350,603451,125,521454,787,851460,790,335462,994,107469,581,068475,092,335480,037,634477,146,968476,241,732478,936,651473,178,423471,236,168460,293,064463,568,070468,300,523469,100,892481,993,003478,468,286480,428,075496,765,557492,278,631484,822,886489,162,038487,333,744498,607,638476,430,139458,366,330425,706,697415,879,308402,396,930401,759,957398,427,200395,100,671394,225,347393,855,836394,584,546378,259,002374,919,313367,919,722367,912,767364,474,075355,502,715349,522,011339,196,270332,345,075336,705,192340,058,137342,984,24291,421,86192,972,73995,724,78196,937,464100,807,070102,567,07399,867,401100,990,757103,573,12596,992,348089,228,32676,440,50774,073,80779,249,72482,009,71181,278,47184,795,29586,775,34487,788,34592,046,71294,660,42498,434,80499,673,41298,843,89197,810,621100,403,540104,937,407108,419,707111,631,966114,509,791120,464,000121,980,732112,021,153100,585,13493,952,102
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
585,736
6,477,896
6,371,728
6,445,736
6,445,736
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000006,445,7366,445,7366,371,7286,477,896585,736000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
844,908
790,280
757,504
713,801
670,099
626,397
582,695
26,160,708
16,940,134
16,314,584
16,313,061
14,584,392
14,386,479
14,112,533
13,386,605
14,420,899
13,637,917
12,470,729
12,561,361
12,000,459
13,006,433
22,643,754
32,214,245
31,258,376
39,355,450
42,191,034
44,491,310
47,701,613
37,862,803
31,288,373
32,364,789
38,838,513
3,085,932
18,899,762
17,915,420
16,931,078
16,950,594
14,962,394
14,964,143
20,167,550
17,063,010
15,688,041
14,310,672
12,950,675
11,714,578
10,432,967
9,151,355
7,869,744
7,546,198
6,293,852
5,020,057
3,759,049
2,498,042
1,599,990
3,357,203
3,122,129
2,878,822
2,150,232
2,150,2322,878,8223,122,1293,357,2031,599,9902,498,0423,759,0495,020,0576,293,8527,546,1987,869,7449,151,35510,432,96711,714,57812,950,67514,310,67215,688,04117,063,01020,167,55014,964,14314,962,39416,950,59416,931,07817,915,42018,899,7623,085,93238,838,51332,364,78931,288,37337,862,80347,701,61344,491,31042,191,03439,355,45031,258,37632,214,24522,643,75413,006,43312,000,45912,561,36112,470,72913,637,91714,420,89913,386,60514,112,53314,386,47914,584,39216,313,06116,314,58416,940,13426,160,708582,695626,397670,099713,801757,504790,280844,90800000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,566,535
18,503,592
0
18,382,949
27,392,404
27,300,457
27,208,510
27,071,563
26,964,615
26,867,313
26,802,455
26,703,079
26,604,202
26,512,753
26,433,050
26,334,906
11,257,360
10,270,396
10,524,714
10,316,057
10,811,023
15,699,917
0
0
9,595,961
0
0
10,873,092
9,783,506
2,722,557
2,686,750
2,650,944
2,338,177
2,579,330
2,266,564
1,982,294
2,362,351
6,448,979
2,964,963
6,634,383
57,190,525
54,320,530
57,019,035
56,944,041
59,194,483
58,860,551
59,207,894
53,758,838
-2,430,058
0
0
0
-261,000
0
0-261,000000-2,430,05853,758,83859,207,89458,860,55159,194,48356,944,04157,019,03554,320,53057,190,5256,634,3832,964,9636,448,9792,362,3511,982,2942,266,5642,579,3302,338,1772,650,9442,686,7502,722,5579,783,50610,873,092009,595,9610015,699,91710,811,02310,316,05710,524,71410,270,39611,257,36026,334,90626,433,05026,512,75326,604,20226,703,07926,802,45526,867,31326,964,61527,071,56327,208,51027,300,45727,392,40418,382,949018,503,59218,566,535000000000000000000000000000000000000
> Total Liabilities 
295,916,724
294,189,572
389,104,206
412,038,740
348,001,000
368,015,244
285,390,331
283,088,542
379,723,626
268,257,971
239,731,487
246,251,192
267,150,734
253,578,089
286,516,233
261,518,438
274,525,198
312,396,235
362,748,528
483,386,655
717,874,313
333,078,766
456,477,466
575,067,562
669,216,335
0
445,210,284
481,423,524
429,313,362
372,467,289
417,456,551
519,056,375
422,689,679
381,984,853
476,234,807
580,845,795
505,707,835
425,371,093
532,424,528
529,546,653
538,516,613
449,859,335
505,934,829
689,606,823
703,717,301
573,059,434
621,877,737
760,305,013
656,380,083
590,230,767
679,240,472
793,180,994
940,999,667
750,908,258
783,460,111
920,886,359
805,876,240
913,379,961
938,171,195
961,479,901
1,003,464,885
912,927,105
938,333,937
1,032,187,435
945,703,749
927,104,466
927,557,464
864,048,192
878,999,867
918,658,464
1,055,033,289
1,005,293,768
1,283,008,182
1,389,417,176
1,519,904,623
1,905,112,100
1,503,569,487
1,469,428,718
1,448,802,937
1,486,959,603
1,447,651,935
1,551,686,144
1,593,062,702
1,596,418,345
1,563,981,236
1,650,330,055
1,727,554,899
1,729,070,281
1,762,201,149
1,363,035,261
1,363,035,2611,762,201,1491,729,070,2811,727,554,8991,650,330,0551,563,981,2361,596,418,3451,593,062,7021,551,686,1441,447,651,9351,486,959,6031,448,802,9371,469,428,7181,503,569,4871,905,112,1001,519,904,6231,389,417,1761,283,008,1821,005,293,7681,055,033,289918,658,464878,999,867864,048,192927,557,464927,104,466945,703,7491,032,187,435938,333,937912,927,1051,003,464,885961,479,901938,171,195913,379,961805,876,240920,886,359783,460,111750,908,258940,999,667793,180,994679,240,472590,230,767656,380,083760,305,013621,877,737573,059,434703,717,301689,606,823505,934,829449,859,335538,516,613529,546,653532,424,528425,371,093505,707,835580,845,795476,234,807381,984,853422,689,679519,056,375417,456,551372,467,289429,313,362481,423,524445,210,2840669,216,335575,067,562456,477,466333,078,766717,874,313483,386,655362,748,528312,396,235274,525,198261,518,438286,516,233253,578,089267,150,734246,251,192239,731,487268,257,971379,723,626283,088,542285,390,331368,015,244348,001,000412,038,740389,104,206294,189,572295,916,724
   > Total Current Liabilities 
295,916,724
289,757,808
384,672,443
373,223,536
308,386,000
343,160,040
260,135,127
257,433,338
353,668,422
240,875,051
211,698,569
219,403,982
239,648,536
230,322,739
262,273,837
236,618,011
248,637,724
284,647,175
333,532,422
452,943,502
686,297,192
299,532,755
421,690,039
538,303,942
634,575,747
0
408,937,658
428,896,699
376,911,513
318,419,352
367,873,865
472,568,084
375,535,696
333,130,367
432,250,392
535,838,362
459,403,522
378,591,880
483,731,142
478,991,464
369,863,737
280,176,240
336,880,501
531,256,912
670,902,757
530,151,485
578,692,691
714,429,446
600,565,585
491,127,886
576,182,291
707,818,010
846,731,121
651,098,094
686,418,394
823,473,214
704,929,716
810,695,546
834,088,784
862,417,495
893,289,027
800,220,579
818,992,384
910,708,114
827,237,833
810,723,661
811,139,862
748,823,389
440,827,007
533,791,554
617,970,377
568,977,259
836,751,938
949,941,349
1,081,509,602
1,272,759,374
1,045,188,438
1,014,848,789
949,358,804
986,911,654
985,245,941
1,101,817,121
1,151,004,523
1,156,470,213
1,231,087,955
1,323,521,209
1,397,917,307
1,420,228,975
1,507,257,321
1,106,732,372
1,106,732,3721,507,257,3211,420,228,9751,397,917,3071,323,521,2091,231,087,9551,156,470,2131,151,004,5231,101,817,121985,245,941986,911,654949,358,8041,014,848,7891,045,188,4381,272,759,3741,081,509,602949,941,349836,751,938568,977,259617,970,377533,791,554440,827,007748,823,389811,139,862810,723,661827,237,833910,708,114818,992,384800,220,579893,289,027862,417,495834,088,784810,695,546704,929,716823,473,214686,418,394651,098,094846,731,121707,818,010576,182,291491,127,886600,565,585714,429,446578,692,691530,151,485670,902,757531,256,912336,880,501280,176,240369,863,737478,991,464483,731,142378,591,880459,403,522535,838,362432,250,392333,130,367375,535,696472,568,084367,873,865318,419,352376,911,513428,896,699408,937,6580634,575,747538,303,942421,690,039299,532,755686,297,192452,943,502333,532,422284,647,175248,637,724236,618,011262,273,837230,322,739239,648,536219,403,982211,698,569240,875,051353,668,422257,433,338260,135,127343,160,040308,386,000373,223,536384,672,443289,757,808295,916,724
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,799,066
86,722,734
0
283,428,532
76,209,887
100,471,590
167,233,131
270,410,686
318,571,187
335,708,233
341,809,077
375,010,920
223,852,873
279,293,513
285,429,207
386,300,725
251,147,988
403,487,124
431,965,177
479,408,480
376,738,131
440,721,038
0
0
455,486,865
0
0
486,349,797
507,583,619
481,172,846
445,367,597
460,269,317
118,622,038
173,704,854
143,934,992
97,539,886
95,322,650
124,783,618
116,388,233
139,317,137
207,316,587
189,992,868
126,801,355
145,603,409
195,313,370
241,143,382
351,476,998
355,862,530
0
0
0
0
0
0
000000355,862,530351,476,998241,143,382195,313,370145,603,409126,801,355189,992,868207,316,587139,317,137116,388,233124,783,61895,322,65097,539,886143,934,992173,704,854118,622,038460,269,317445,367,597481,172,846507,583,619486,349,79700455,486,86500440,721,038376,738,131479,408,480431,965,177403,487,124251,147,988386,300,725285,429,207279,293,513223,852,873375,010,920341,809,077335,708,233318,571,187270,410,686167,233,131100,471,59076,209,887283,428,532086,722,73480,799,066000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
481,172,846
445,367,597
460,269,317
118,622,038
173,704,854
143,934,992
97,539,886
91,858,005
119,613,630
114,036,289
137,581,942
203,089,853
185,340,814
122,164,713
141,178,482
193,038,119
238,972,554
348,242,728
352,713,637
403,285,652
431,957,520
445,352,670
510,992,638
522,734,523
441,491,139
441,491,139522,734,523510,992,638445,352,670431,957,520403,285,652352,713,637348,242,728238,972,554193,038,119141,178,482122,164,713185,340,814203,089,853137,581,942114,036,289119,613,63091,858,00597,539,886143,934,992173,704,854118,622,038460,269,317445,367,597481,172,84600000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
77,664,979
0
171,314,680
71,490,000
100,599,860
112,051,718
103,884,613
180,975,923
152,640,588
135,851,016
114,919,286
104,795,993
171,119,206
163,277,194
101,828,962
119,628,949
171,349,890
184,003,004
282,309,449
390,011,329
119,757,407
158,945,314
264,651,418
278,092,339
0
152,906,088
169,523,402
213,445,709
128,476,387
134,929,650
197,727,754
232,162,707
164,168,440
214,741,423
212,582,063
289,874,104
206,160,213
208,064,003
100,296,161
247,767,443
151,605,250
147,391,313
233,201,795
304,641,012
143,936,034
191,777,207
305,021,443
334,684,119
161,272,064
234,106,645
270,086,226
545,995,386
186,411,000
211,581,869
291,279,552
284,808,368
309,989,882
338,074,553
339,018,140
385,141,810
219,969,003
199,732,781
279,425,531
213,561,803
196,895,287
265,857,168
174,665,021
229,722,202
253,369,008
321,563,133
328,316,344
602,640,634
642,587,029
659,238,521
773,858,226
568,662,774
545,469,184
526,315,699
535,278,885
525,884,211
563,939,495
498,978,674
488,074,592
488,687,269
503,390,713
536,238,674
483,930,711
499,250,481
275,972,470
275,972,470499,250,481483,930,711536,238,674503,390,713488,687,269488,074,592498,978,674563,939,495525,884,211535,278,885526,315,699545,469,184568,662,774773,858,226659,238,521642,587,029602,640,634328,316,344321,563,133253,369,008229,722,202174,665,021265,857,168196,895,287213,561,803279,425,531199,732,781219,969,003385,141,810339,018,140338,074,553309,989,882284,808,368291,279,552211,581,869186,411,000545,995,386270,086,226234,106,645161,272,064334,684,119305,021,443191,777,207143,936,034304,641,012233,201,795147,391,313151,605,250247,767,443100,296,161208,064,003206,160,213289,874,104212,582,063214,741,423164,168,440232,162,707197,727,754134,929,650128,476,387213,445,709169,523,402152,906,0880278,092,339264,651,418158,945,314119,757,407390,011,329282,309,449184,003,004171,349,890119,628,949101,828,962163,277,194171,119,206104,795,993114,919,286135,851,016152,640,588180,975,923103,884,613112,051,718100,599,86071,490,000171,314,680077,664,9790
       Other Current Liabilities 
0
61,299,968
0
36,454,555
31,034,000
102,341,590
71,828,789
61,095,199
83,989,388
72,734,463
30,575,980
25,420,636
27,188,724
37,727,282
32,127,170
28,462,738
27,994,489
47,671,467
52,810,753
53,155,711
116,438,505
64,452,986
38,334,859
55,476,327
78,752,212
0
33,235,978
40,006,660
75,928,727
32,983,107
48,384,164
41,822,248
54,245,777
48,269,687
46,995,745
69,146,245
378,604,456
71,075,768
52,927,753
90,342,270
39,146,391
0
19,790,101
26,753,474
45,484,860
0
0
0
28,700,024
0
40,112,532
34,873,814
30,305,026
0
0
0
29,012,755
0
62,270,279
56,434,671
23,096,734
55,995,974
93,006,223
95,930,680
52,943,904
0
45,426,255
57,386,357
15,988,172
26,988,607
57,452,723
92,497,504
7,784,828
7,784,828
7,784,828
4,560,323
39,029,537
279,386,738
277,098,744
287,991,313
260,876,550
288,185,651
295,840,941
306,669,348
0
0
0
0
0
0
000000306,669,348295,840,941288,185,651260,876,550287,991,313277,098,744279,386,73839,029,5374,560,3237,784,8287,784,8287,784,82892,497,50457,452,72326,988,60715,988,17257,386,35745,426,255052,943,90495,930,68093,006,22355,995,97423,096,73456,434,67162,270,279029,012,75500030,305,02634,873,81440,112,532028,700,02400045,484,86026,753,47419,790,101039,146,39190,342,27052,927,75371,075,768378,604,45669,146,24546,995,74548,269,68754,245,77741,822,24848,384,16432,983,10775,928,72740,006,66033,235,978078,752,21255,476,32738,334,85964,452,986116,438,50553,155,71152,810,75347,671,46727,994,48928,462,73832,127,17037,727,28227,188,72425,420,63630,575,98072,734,46383,989,38861,095,19971,828,789102,341,59031,034,00036,454,555061,299,9680
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,304,313
46,779,213
0
50,555,189
168,652,877
169,683,095
169,054,328
158,349,910
32,814,545
42,907,949
43,185,046
45,875,567
55,814,498
99,102,882
103,058,181
85,362,984
94,268,547
99,810,164
97,041,717
97,413,145
100,946,525
102,684,415
0
0
110,175,857
0
0
121,479,321
118,465,916
116,380,804
116,417,602
115,224,803
438,172,860
384,866,910
437,062,912
436,316,509
446,256,244
439,475,826
438,395,021
632,352,727
458,381,048
454,579,928
499,444,132
500,047,949
462,405,994
449,869,022
442,058,178
439,948,133
332,893,281
326,808,846
329,637,592
308,841,305
254,943,828
256,302,889
256,302,889254,943,828308,841,305329,637,592326,808,846332,893,281439,948,133442,058,178449,869,022462,405,994500,047,949499,444,132454,579,928458,381,048632,352,727438,395,021439,475,826446,256,244436,316,509437,062,912384,866,910438,172,860115,224,803116,417,602116,380,804118,465,916121,479,32100110,175,85700102,684,415100,946,52597,413,14597,041,71799,810,16494,268,54785,362,984103,058,18199,102,88255,814,49845,875,56743,185,04642,907,94932,814,545158,349,910169,054,328169,683,095168,652,87750,555,189046,779,21346,304,313000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,078,371
364,693,620
364,002,562
363,521,254
361,490,025
362,170,180
353,892,945
351,193,528
344,250,608
397,521,286
392,557,803
435,224,173
434,177,990
431,899,687
421,426,243
416,843,630
415,861,828
0
0
0
0
0
0
000000415,861,828416,843,630421,426,243431,899,687434,177,990435,224,173392,557,803397,521,286344,250,608351,193,528353,892,945362,170,180361,490,025363,521,254364,002,562364,693,62044,078,3710000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
1,565,097
0
3,315,204
4,115,000
5,355,204
5,755,204
6,155,204
6,555,204
21,382,920
22,032,918
20,847,210
21,502,198
23,255,350
24,242,396
24,900,427
25,887,474
27,749,059
29,216,106
30,443,153
31,577,121
33,546,011
34,787,427
36,763,620
34,640,587
0
36,272,626
36,055,365
36,652,537
38,298,626
38,812,115
40,451,598
41,542,124
43,111,318
43,417,685
44,440,703
45,864,393
46,437,758
48,055,432
49,829,203
49,393,682
50,415,018
50,133,007
30,595,813
32,741,329
34,145,674
34,471,857
34,369,311
40,186,170
39,186,048
43,129,623
34,229,783
44,537,244
47,206,234
47,547,257
49,438,064
56,211,982
57,876,930
59,249,867
59,161,825
65,457,066
67,987,735
69,902,189
72,039,957
67,707,360
69,432,436
68,967,118
71,146,432
73,479,240
70,923,808
73,541,658
74,826,484
84,086,064
85,582,882
87,201,493
288,102,119
60,859,762
62,022,125
64,219,959
65,869,959
0
0
25,214,549
0
0
0
0
0
0
0
000000025,214,5490065,869,95964,219,95962,022,12560,859,762288,102,11987,201,49385,582,88284,086,06474,826,48473,541,65870,923,80873,479,24071,146,43268,967,11869,432,43667,707,36072,039,95769,902,18967,987,73565,457,06659,161,82559,249,86757,876,93056,211,98249,438,06447,547,25747,206,23444,537,24434,229,78343,129,62339,186,04840,186,17034,369,31134,471,85734,145,67432,741,32930,595,81350,133,00750,415,01849,393,68249,829,20348,055,43246,437,75845,864,39344,440,70343,417,68543,111,31841,542,12440,451,59838,812,11538,298,62636,652,53736,055,36536,272,626034,640,58736,763,62034,787,42733,546,01131,577,12130,443,15329,216,10627,749,05925,887,47424,900,42724,242,39623,255,35021,502,19820,847,21022,032,91821,382,9206,555,2046,155,2045,755,2045,355,2044,115,0003,315,20401,565,0970
> Total Stockholder Equity
430,196,235
510,844,463
495,566,509
390,435,501
356,407,000
260,865,170
251,444,102
248,821,075
260,920,146
255,664,672
253,397,045
245,865,213
254,813,234
265,245,147
263,739,373
259,759,991
248,457,789
279,386,325
274,577,879
268,500,843
291,562,629
282,017,785
265,831,117
275,655,330
296,594,528
296,595,341
250,774,943
251,967,639
298,720,166
278,408,124
257,341,206
266,872,135
311,266,810
291,277,268
287,918,140
331,984,730
609,192,393
609,332,588
615,331,497
629,225,411
650,100,577
639,134,856
636,562,380
584,694,594
590,792,019
552,407,260
539,890,638
555,120,799
591,958,093
572,013,489
568,152,566
559,985,104
592,705,033
573,130,245
564,839,248
562,297,119
575,753,992
540,922,226
522,213,988
511,605,412
526,408,631
517,922,975
526,661,752
491,314,113
496,646,167
474,873,423
472,289,354
461,803,918
504,933,640
483,155,057
500,272,078
486,052,116
430,321,799
432,141,228
431,299,580
433,146,400
508,295,782
457,113,135
417,580,760
325,185,593
86,359,127
24,562,633
-33,986,910
-105,340,763
-804,133,827
-858,077,366
-906,072,375
-970,616,100
-1,144,019,857
-788,956,024
-788,956,024-1,144,019,857-970,616,100-906,072,375-858,077,366-804,133,827-105,340,763-33,986,91024,562,63386,359,127325,185,593417,580,760457,113,135508,295,782433,146,400431,299,580432,141,228430,321,799486,052,116500,272,078483,155,057504,933,640461,803,918472,289,354474,873,423496,646,167491,314,113526,661,752517,922,975526,408,631511,605,412522,213,988540,922,226575,753,992562,297,119564,839,248573,130,245592,705,033559,985,104568,152,566572,013,489591,958,093555,120,799539,890,638552,407,260590,792,019584,694,594636,562,380639,134,856650,100,577629,225,411615,331,497609,332,588609,192,393331,984,730287,918,140291,277,268311,266,810266,872,135257,341,206278,408,124298,720,166251,967,639250,774,943296,595,341296,594,528275,655,330265,831,117282,017,785291,562,629268,500,843274,577,879279,386,325248,457,789259,759,991263,739,373265,245,147254,813,234245,865,213253,397,045255,664,672260,920,146248,821,075251,444,102260,865,170356,407,000390,435,501495,566,509510,844,463430,196,235
   Common Stock
0
309,687,500
0
309,926,750
309,927,000
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
0
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
309,926,750
0
0
0
0
0
0
000000309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,7500309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,926,750309,927,000309,926,7500309,687,5000
   Retained Earnings 
45,119,243
117,624,723
110,539,403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,820,856
20,961,051
26,959,960
40,853,874
61,729,041
50,763,319
46,919,290
-4,948,496
1,148,929
-37,235,830
-49,752,452
-34,522,291
2,315,003
-17,629,601
-21,490,524
-29,657,986
206,355,787
186,781,000
178,490,003
175,947,874
183,385,042
148,553,277
131,116,592
120,508,016
134,039,682
126,825,579
135,564,356
98,945,163
104,277,217
82,504,473
79,920,404
69,434,968
-79,300,153
90,786,108
-83,961,714
-98,181,676
-150,252,017
-148,432,589
-149,274,236
-147,427,416
-187,832,657
-239,015,304
-278,547,679
-370,942,847
-616,295,611
-678,092,105
-736,641,647
-807,995,501
-1,411,547,457
-1,465,490,996
-1,513,486,005
-1,578,029,730
-1,746,036,031
-1,378,184,410
-1,378,184,410-1,746,036,031-1,578,029,730-1,513,486,005-1,465,490,996-1,411,547,457-807,995,501-736,641,647-678,092,105-616,295,611-370,942,847-278,547,679-239,015,304-187,832,657-147,427,416-149,274,236-148,432,589-150,252,017-98,181,676-83,961,71490,786,108-79,300,15369,434,96879,920,40482,504,473104,277,21798,945,163135,564,356126,825,579134,039,682120,508,016131,116,592148,553,277183,385,042175,947,874178,490,003186,781,000206,355,787-29,657,986-21,490,524-17,629,6012,315,003-34,522,291-49,752,452-37,235,8301,148,929-4,948,49646,919,29050,763,31961,729,04140,853,87426,959,96020,961,05120,820,856000000000000000000000000000000000110,539,403117,624,72345,119,243
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
81,120,061
0
0
0
0
0
0
00000081,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,06181,120,0610000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
278,444,787
278,444,787
0
278,444,787
278,444,787
278,444,787
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
279,716,340
76,422,495
76,422,495
76,422,495
76,422,495
82,442,200
82,442,200
0
0
82,442,200
0
0
82,442,200
82,442,200
82,442,200
82,442,200
82,442,200
274,307,042
82,442,200
274,307,042
274,307,042
270,647,066
270,647,066
270,647,066
270,647,066
386,201,689
386,201,689
284,413,778
284,413,778
284,413,778
284,413,778
284,413,778
284,413,778
0
0
0
0
0
0
000000284,413,778284,413,778284,413,778284,413,778284,413,778284,413,778386,201,689386,201,689270,647,066270,647,066270,647,066270,647,066274,307,042274,307,04282,442,200274,307,04282,442,20082,442,20082,442,20082,442,20082,442,2000082,442,2000082,442,20082,442,20076,422,49576,422,49576,422,49576,422,495279,716,340279,716,340279,716,340279,716,340279,716,340279,716,340279,716,340279,716,340279,716,340279,716,340278,444,787278,444,787278,444,7870278,444,787278,444,787000000000000000000000000000000000000



6.3. Balance Sheets

Currency in IDR. All numbers in thousands.




6.4. Cash Flows

Currency in IDR. All numbers in thousands.




6.5. Income Statements

Currency in IDR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in IDR. All numbers in thousands.

Gross Profit (+$)
totalRevenue210,379,674
Cost of Revenue-247,887,351
Gross Profit-37,507,678-37,507,678
 
Operating Income (+$)
Gross Profit-37,507,678
Operating Expense-442,177,918
Operating Income-231,798,244-479,685,595
 
Operating Expense (+$)
Research Development0
Selling General Administrative49,876,237
Selling And Marketing Expenses0
Operating Expense442,177,91849,876,237
 
Net Interest Income (+$)
Interest Income105,924
Interest Expense-30,014,478
Other Finance Cost-0
Net Interest Income-29,908,554
 
Pretax Income (+$)
Operating Income-231,798,244
Net Interest Income-29,908,554
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-283,757,709-231,798,244
EBIT - interestExpense = -30,014,478
-334,488,575
-304,474,097
Interest Expense30,014,478
Earnings Before Interest and Taxes (EBIT)0-253,743,230
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-283,757,709
Tax Provision-50,734,479
Net Income From Continuing Ops-334,492,187-334,492,187
Net Income-334,488,575
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net029,908,554
 

Technical Analysis of Indofarma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Indofarma. The general trend of Indofarma is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Indofarma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Indofarma Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Indofarma Tbk.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 126.00 < 126.00 < 126.00.

The bearish price targets are: 126.00 > 126.00 > 126.00.

Know someone who trades $INAF? Share this with them.πŸ‘‡

Indofarma Tbk Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Indofarma Tbk. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Indofarma Tbk Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Indofarma Tbk. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Indofarma price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Indofarma. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Indofarma price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Indofarma Tbk Daily Moving Average Convergence/Divergence (MACD) ChartIndofarma Tbk Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Indofarma Tbk. The current adx is 44.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Indofarma shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Indofarma Tbk Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Indofarma Tbk. The current sar is 126.00.

Indofarma Tbk Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Indofarma Tbk. The current rsi is 24.56. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Indofarma Tbk Daily Relative Strength Index (RSI) ChartIndofarma Tbk Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Indofarma Tbk. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Indofarma price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Indofarma Tbk Daily Stochastic Oscillator ChartIndofarma Tbk Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Indofarma Tbk. The current cci is 0.

Indofarma Tbk Daily Commodity Channel Index (CCI) ChartIndofarma Tbk Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Indofarma Tbk. The current cmo is 0.

Indofarma Tbk Daily Chande Momentum Oscillator (CMO) ChartIndofarma Tbk Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Indofarma Tbk. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Indofarma Tbk Daily Williams %R ChartIndofarma Tbk Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Indofarma Tbk.

Indofarma Tbk Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Indofarma Tbk. The current atr is 0.0000.

Indofarma Tbk Daily Average True Range (ATR) ChartIndofarma Tbk Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Indofarma Tbk. The current obv is 9,111,300.

Indofarma Tbk Daily On-Balance Volume (OBV) ChartIndofarma Tbk Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Indofarma Tbk. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Indofarma Tbk Daily Money Flow Index (MFI) ChartIndofarma Tbk Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Indofarma Tbk.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Indofarma Tbk Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Indofarma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.556
Ma 20Greater thanMa 50126.000
Ma 50Greater thanMa 100126.000
Ma 100Greater thanMa 200126.000
OpenGreater thanClose126.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Indofarma with someone you think should read this too:
  • Are you bullish or bearish on Indofarma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Indofarma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Indofarma Tbk

I send you an email if I find something interesting about Indofarma Tbk.


Comments

How you think about this?

Leave a comment

Stay informed about Indofarma Tbk.

Receive notifications about Indofarma Tbk in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.